Our Vision

At Molecular You, we believe health decisions should be guided by deeper biological insight. Using advanced quantitative molecular analysis, we provide greater visibility into how the body is functioning across systems. Our goal is to give individuals and clinicians clear, science-based information that supports more informed, proactive care.

Our Vision

Our Story

Molecular You was founded in 2014 in Vancouver, BC, as a spin-off of the Personalized Medicine Initiative (PMI). Rob Fraser, PhD, co-founded PMI alongside leading Canadian scientists and clinicians to advance the field of individualized medicine, with the goal of tailoring healthcare to each person’s unique biology. Molecular You was created to bring this work into practice by combining multi-omic technologies with clinically relevant health insight.

Since its founding, Molecular You has focused on translating complex molecular data into information that can be used in real-world care. By integrating metabolomics, proteomics, and advanced analytics, the company has grown from a research-driven startup into a leader in predictive and systems-based health assessment.

Our Approach

By analyzing molecular data, we assess 190+ biomarkers across 7 systems, 27+ processes, and 15 disease categories, from diabetes and cardiovascular disease to Alzheimer’s. Our approach integrates advanced analytics and AI to generate interconnected, personalized insights that help healthcare providers better understand underlying biological patterns and support more proactive care.

Our mission is to make molecular medicine more accessible and clinically useful, supporting a shift toward predictive and preventive care while helping practices offer a more advanced, data-driven approach to patient health.

Our History

2014: Molecular You founded out of the Personalized Medicine Initiative.
2018: Received the TEC Edmonton Spin-Off Achievement Award for advancing personalized health technologies in collaboration with The Metabolomics Innovation Centre (TMIC).
2023: Launched a consumer solution across Canada, making personalized health insights accessible nationwide.
2023: Welcomed Jim Kean as CEO to lead our next phase of growth.
2024: Appointed Dr. Murdoc Khaleghi as Chief Medical Officer.
2024: Announced partnership with HealthQuest Esoterics laboratory to bring Molecular You services to the U.S.
2024: Won the Digital Health Rising Star Award in Longevity, recognizing our commitment to innovative health solutions.

Founded by Leaders in Molecular Science

Our work is built on decades of scientific research led by internationally recognized experts in molecular medicine. Dr. Pieter Cullis, co-founder and board chair, is a professor at the University of British Columbia and a pioneer in lipid nanoparticle technology, widely used in modern drug delivery and RNA-based therapeutics. His research has influenced the development of personalized medicine and helped inform the scientific direction behind Molecular You.

Professor David Wishart, co-founder and advisor, leads the Wishart Lab at the University of Alberta and is an internationally recognized researcher in metabolomics and biomarker discovery. His work has contributed to major metabolomic databases used in research worldwide and has advanced the use of molecular data to understand human health at the systems level.

Through ongoing collaboration with universities, research institutes, and clinical partners, Molecular You continues to build on this scientific foundation to translate complex molecular data into meaningful health insight.